Filgrastim
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Filgrastim and local guidelines before prescribing.
Haematopoietic growth factor
Mechanism
Granulocyte colony-stimulating factor.
Uses
Febrile neutropenia prevention, stem-cell mobilisation, severe chronic neutropenia.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Bone pain, splenic rupture (rare), leucocytosis, ARDS.
Interactions
Cytotoxic chemotherapy timing.
Contraindications and cautions
Severe congenital neutropenia caution
Monitoring
FBC
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
No adjustment
Overdose and reversal
Supportive
Special advice
Do not give within 24 hours of cytotoxic chemotherapy; monitor neutrophils.
More from the textbook: uses, cautions and other points
- Growth factors control production - erythropoietin (kidney - red cells), thrombopoietin (liver - platelets), G-CSF (neutrophils), interleukins. Several are given as drugs.
Haematology: Anatomy Physiology and Pharmacology - Raised white count | Steroids (neutrophilia), lithium, G-CSF, adrenaline
Haematology: Anatomy Physiology and Pharmacology - Filgrastim (G-CSF) | Neutropenia after chemotherapy; bone pain, splenic rupture.
Haematology: Anatomy Physiology and Pharmacology - G-CSF treatment causes bone pain.
Haematology: History and Examination - G-CSF may speed recovery.
Haematology: Emergencies - IV piperacillin–tazobactam within 1 hour; consider G-CSF.
Haematology: Emergencies - Growth factors: G-CSF (filgrastim) shortens neutropenia after some chemotherapy.
Haematology: Leukaemias, myeloproliferative neoplasms and myelodysplasia - G-CSF can prevent or shorten neutropenia.
Oncology: Principles
Where it is discussed in the book
- Haematology: Anatomy Physiology and Pharmacology (3 mentions)
- Haematology: History and Examination (1 mention)
- Haematology: Emergencies (2 mentions)
- Haematology: Leukaemias, myeloproliferative neoplasms and myelodysplasia (1 mention)
- Oncology: Principles (3 mentions)
- Oncology: Emergencies (2 mentions)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (1 mention)
- ID: Hospital infection, the immunocompromised host, vaccination and public health (1 mention)
- Clinical Immunology: Primary immunodeficiency (1 mention)
- Clinical Immunology: Secondary immunodeficiency, the immunocompromised host and vaccination (2 mentions)
- 0231 (1 mention)
- 0269-miscellaneous-conditions-a-z (2 mentions)